NEW YORK (GenomeWeb News) – Life Technologies Chairman and CEO Greg Lucier could see a $38.1 million payday upon completion of Thermo Fisher Scientific's acquisition of the company, Life Tech said in its definitive proxy statement.

Similarly, other executives at the company could see large financial gains from the $13.6 billion deal announced in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.